tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

Search every filing

2,477,667 paragraphs from 10-Ks, 10-Qs and 8-Ks with press releases.

Matching paragraphs

9 paragraphs · newest first, each linked to its filing
ABT Abbott Laboratories 10-K Feb 21, 2025 · 10-K

The CISO leads Abbott’s cybersecurity strategy and program and its cybersecurity and privacy incident response team that is responsible for monitoring the detection of cybersecurity incidents and executing Abbott’s cybersecurity incident response process, as needed. Pursuant to the process, the team is responsible for the investigation and resolution of cybersecurity incidents, including reporting to an Abbott senior management-level committee on detection, mitigation, and remediation of significant cybersecurity incidents. The CISO reports to the CIO, who has overall responsibility for the cybersecurity program and organization.

Read in the filing ↗ Also in 10-K of Feb 20, 2026
ABT Abbott Laboratories 10-K Feb 21, 2025 · 10-K

• dedicated cybersecurity professionals who are responsible for analyzing cybersecurity threats, defining cybersecurity policy and requirements, implementing protections, and monitoring and responding to cybersecurity incidents;

Read in the filing ↗ Also in 10-K of Feb 20, 2026
ABT Abbott Laboratories 10-K Feb 21, 2025 · 10-K

Abbott has two cross-functional senior management-level committees that assess Abbott’s material risks from cybersecurity threats - one that oversees Abbott’s cybersecurity program and another that oversees the cybersecurity incident response process.

Read in the filing ↗ Also in 10-K of Feb 20, 2026
ABT Abbott Laboratories 10-K Feb 21, 2025 · 10-K

• cybersecurity monitoring and response processes intended to identify, assess, escalate, investigate, contain, and remediate incidents; and

Read in the filing ↗ Also in 10-K of Feb 20, 2026
ABT Abbott Laboratories 10-K Feb 21, 2025 · Item 1A, Risk Factors

Abbott invests in its information systems and technology and in the protection of its products and data to reduce the risk of a cybersecurity incident or other significant disruption, and monitors its information systems on an ongoing basis for any current or potential cybersecurity threats or vulnerabilities and for changes in technology and the regulatory environment. There can be no assurance that these measures and efforts will prevent future cybersecurity incidents or other significant disruptions to any of the information systems on which Abbott relies or that related product issues will not arise in the future. Similarly, there can be no assurance that third party information technology providers or other partners with whom Abbott contracts will not suffer a significant cybersecurity incident or disruption that impacts Abbott. Any significant cybersecurity incident or other disruption affecting Abbott’s information systems or products could have a material adverse effect on Abbott’s business, financial condition and results of operations.

Read in the filing ↗ Also in 10-K of Feb 20, 2026
ABT Abbott Laboratories 10-K Feb 21, 2025 · Item 1A, Risk Factors

Similar to other large multi-national companies, the size and complexity of the information systems on which Abbott relies for both its infrastructure and products make them susceptible to a cybersecurity incident, breakdown, destruction, loss of data privacy, or other significant disruption. These systems have been and are expected to continue to be the target of malware and other cybersecurity incidents. In addition, third party hacking attempts may cause Abbott’s information systems and related products, protected data, or proprietary information to be compromised or stolen. A significant cybersecurity incident or other disruption could result in adverse consequences, including regulatory inquiries or litigation, increased costs and expenses, manufacturing challenges or disruption, problems with product availability, functionality or safety, damage to customer relations, reputational damage, lost revenue, and fines or penalties.

Read in the filing ↗ Also in 10-K of Feb 20, 2026
ABT Abbott Laboratories 10-K Feb 21, 2025 · Item 1A, Risk Factors

Abbott depends on sophisticated information systems and maintains protected personal data, and a significant cybersecurity incident or other disruption affecting these information systems or protected data could have a material adverse effect on Abbott’s business, financial condition and results of operations.

Read in the filing ↗ Also in 10-K of Feb 20, 2026
ABT Abbott Laboratories 10-K Feb 21, 2025 · 10-K

A discussion of how Abbott’s business, results of operations, and financial condition could be materially adversely affected by risks from cybersecurity threats is contained in Item 1A. Risk Factors under “Abbott depends on sophisticated information systems and maintains protected personal data, and a significant cybersecurity incident or other disruption affecting these information systems or protected personal data could have a material adverse effect on Abbott’s business, financial condition and results of operations."

Read in the filing ↗ Also in 10-K of Feb 20, 2026
ABT Abbott Laboratories 10-K Feb 21, 2025 · Item 1A, Risk Factors

The manufacture of many of Abbott’s products is a highly exacting and complex process, due in part to strict regulatory requirements. Problems may arise during manufacturing for a variety of reasons, including equipment malfunction, failure to follow specific protocols and procedures, problems with raw materials or the global supply chain, failure to meet product specifications, cybersecurity incidents, natural disasters, and environmental factors. In addition, single suppliers are currently used for certain products and materials. If problems arise during the production of a lot or batch of product, those products may have to be discarded. If problems are not discovered before the product is released to the market, recall and product liability costs may also be incurred. Any of these events could, among other things, lead to increased costs, lost revenue, damage to customer relations, reputational damage, time and expense spent investigating the cause and remediating the problem, if any, a production stoppage at a manufacturing facility, and depending on the cause, similar losses with respect to other lots, batches or products. To the extent Abbott or one of its suppliers or manufacturers experiences significant manufacturing problems, this could have a material adverse effect on Abbott’s revenues and profitability.

Read in the filing ↗ Also in 10-K of Feb 20, 2026